CRP and diabetes mellitus: Identifying reliable prognostic markers such as NLR and CRP and understanding the dysregulation of calcium homeostasis will help improve the diagnosis and management of T2D and confirm the importance of new therapeutic targets to treat diabetes. Future research is necessary to understand better the potential role of additional clinical markers to help improve the diagnosis and treatment of T2D.